We also evidenced that uPAR KO mediated by CRISPR/Cas9 is able to induce a stem-like phenotype in melanoma and colon carcinoma cells, overexpressing stem-related antigens and transcription factors and enhancing their self-renewal capabilities. Here, PLAUR is linked to colon carcinoma.